Skip to main content
Signal8
BYOM JOHN E profile photo

John E. Byom

CIK: 0001202329

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Prestige Consumer Healthcare Inc. logo
PBH

Prestige Consumer Healthcare Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Prestige Consumer Healthcare Inc. logo
    PBH

    Prestige Consumer Healthcare Inc.

    Aug 4, 2026
    Award(A)
    Direct
    3K shares-
  • Prestige Consumer Healthcare Inc. logo
    PBH

    Prestige Consumer Healthcare Inc.

    Nov 25, 2025
    Sale(S)
    Direct
    3K shares at avg. $59.35$178K
  • Prestige Consumer Healthcare Inc. logo
    PBH

    Prestige Consumer Healthcare Inc.

    Aug 5, 2025
    Award(A)
    Direct
    2.1K shares-

1-3 of 3

About BYOM JOHN E

BYOM JOHN E (SEC CIK 0001202329) files insider reports with the SEC as Director of Prestige Consumer Healthcare Inc. (PBH).

Signal8 holds 3 ownership filings by BYOM JOHN E, all Form 4s, filed between Aug 6, 2025 and Aug 5, 2026. Those filings report 3 transactions, from Aug 5, 2025 to Aug 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on BYOM JOHN E's filings is in TARRYTOWN, NY.

Recent filings by BYOM JOHN E

  • Aug 4, 2026: Grant or award of PBH shares (Form 4, code A).
  • Nov 25, 2025: Open-market sale of PBH shares (Form 4, code S).
  • Aug 5, 2025: Grant or award of PBH shares (Form 4, code A).

Other insiders filing for Prestige Consumer Healthcare Inc. (PBH)

How to read Form 4 transaction codes